Malin Hultcrantz, MD, PhD

About Me

  • Clinical Expertise: Multiple Myeloma; Smoldering Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS); Related Plasma Cell Disorders
  • Awards and Honors: Multiple Myeloma Research Foundation, Research Fellow Award (2015)
  • Languages Spoken: English; Swedish
  • Education: MD, Karolinska Institute; PhD, Karolinska Institute
  • Residencies: Internal Medicine - University Hospital Orebro, Sweden
  • Fellowships: Hematology/Internal Medicine - Karolinska University Hospital; Advanced Oncology Fellowship - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Hematology; Internal Medicine

See My Colleagues


Visit PubMed for a full listing of Malin Hultcrantz’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.